Winship event recognizes clinical trials milestones

Nearly 150 attendees from six different Winship locations gathered on Feb. 26 to recognize a milestone year for Winship clinical trials and the people who helped make it happen. An interactive panel discussion with clinical research coordinators (Monique Williams and Katie Coleman) and physicians (Drs. Christina Wu and Mehmet Asim Bilen) provided insight into approaches that will enable more patients to benefit from innovative treatment options. Pictured: panelists Christina Wu, MD and Katie Coleman.

Corbett receives ASBMB leadership award

Anita Corbett, PhD is the recipient of the American Society for Biochemistry and Molecular Biology (ASBMB) Mid-Career Leadership Award. The award recognizes her commitment to advancing the careers of women in biochemistry and molecular biology along with demonstrated excellence in research, discovery and/or service.

Winship team develops novel risk scoring system

Winship investigators, led by Mehmet Asim Bilen, MD and medical student Julie Shabto, have developed the Emory Risk Scoring System for patients with urothelial cancer receiving immune checkpoint inhibitors. Their findings were published Feb. 25 in Cancer Medicine.

Winship physicians join Hawks for prostate cancer check presentation

Throughout the month of February, the Atlanta Hawks Foundation pledged to donate $250 per assist to help fight prostate cancer. During the Hawks game on Feb. 28, Winship prostate cancer specialists Drs. Karen Godette, Martin Sanda, and Haydn Kissick joined the Hawks to accept a check for $168,000 on behalf of the Prostate Cancer Foundation. Attendees included Hawks owner Tony Ressler, David Lee, E.V.P. of external affairs and executive director of the Atlanta Hawks Foundation, and Hugh Smith, who was treated for prostate cancer at Winship.

Ready phase one

Surgery and chemo kept Michael Golden’s kidney cancer in check for years, but when it came back, Winship doctors recommended a Phase I clinical trial to get a new treatment. Golden was one of the first patients to be treated in Winship's new Phase I Clinical Trials Unit. His story and others who participate in this earliest phase of cancer research are featured in Emory Medicine Magazine.

Tracking the invasive behavior of “leader” cells

Research by Adam Marcus, PhD and colleagues, first published in October in the Journal of Cell Science, is highlighted in Emory Medicine Magazine. The investigators, led by graduate students Elizabeth Zoeller and Brian Pedro, have developed ways to track mutations that are specific to “leader” or “follower” cells and impact invasion.

Physicians: Vote Emory in US News Best Hospitals survey

The U.S. News and World Report Best Hospitals survey is now open for all eligible Doximity physician members. Eligible Doximity members can complete the survey by logging in to Doximity.com or the Doximity mobile app through March.

Learn More

Treating metastatic melanoma: a case report

Winship physicians Drs. Ragini Kudchadkar, Michael Lowe, and Mohammad Khan and nurse Stephanie McBrien, BSN, RN, OCN describe treating a patient with metastatic melanoma in a new case report for CA: A Journal for Cancer Clinicians published Feb. 26.

Meeting focuses on lung cancer stigma

Drs. Drew Moghanaki and Kristin Higgins participated in the National Lung Cancer Roundtable (NLCR) Eliminating Lung Cancer Stigma meeting held Feb. 26-27 at the Atlanta Hilton. Pictured: NLCR Director Lauren Rosenthal, MPH, Higgins, and Moghanaki.

Winship Clinical Trials Office holds annual retreat

The Winship Clinical Trials Office held its 7th annual retreat on Feb. 28 at the Courtyard by Marriott in Decatur. More than 100 attendees participated in a full day of educational presentations, breakout sessions, and team building activities.